Inactivating somatic mutations in ATRX, DAXX, and MEN1 represent the major mutations encountered in pancreatic NETs, but are much less frequent in their thoracopulmonary counterparts, indicating distinct site-dependent genetic pathways driving these tumors [11, 16]. This evidence concerns the gene DAXX and pancreatic neuroendocrine tumor.